Other Conditions & Exposures

Expert reports about Other Conditions & Exposures


THE SAFETY OF HYDROXYPROGESTERONE CAPROATE (MAKENA) DURING PREGNANCY OR BREASTFEEDING

 

THIS MEDICATION CAN CAUSE HARM TO YOUR BABY:

Evidence on the use of hydroxyprogesterone caproate before 16 weeks gestation suggests a possible risk of birth defects. It is important to weigh the risks versus benefits for the mother and developing baby before using this medication during pregnancy.


TO READ THE FULL REPORT

Join Pregistry to access the information you need at no cost to you

Join Pregistry